| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.004 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.004 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |